HuGE Literature Finder
Records 1-6
|
Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.
Cancer epidemiology 2013 Oct 37 (5): 5. Chiang HC, Lee H, Chao HR, Chiou YH, Tsou TC |
|
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
Toxicology letters 2013 Jan 216 (1): 16-22. Chung Chi-Jung, Pu Yeong-Shiau, Shiue Horng-Sheng, Lee Hui-Ling, Lin Pinpin, Yang Hsiu-Yuan, Su Chien-Tien, Hsueh Yu-M |
|
CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.
Pancreas 2010 Mar 39 (2): 144-8. Mohelnikova-Duchonova Beatrice, Vrana David, Holcatova Ivana, Ryska Miroslav, Smerhovsky Zdenek, Soucek Pav |
|
Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe.
Neoplasma 2010 57 (5): 415-21. Soucek P, Susova S, Mohelnikova-Duchonova B, Gromadzinska J, Moraviec-Sztandera A, Vodicka P, Vodickova |
|
Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population.
Journal of translational medicine 2004 Jun 2 (1): 24. Jiang Ju-Hong, Jia Wei-Hua, Chen Han-Kui, Feng Bing-Jian, Qin Hai-De, Pan Zhi-Gang, Shen Guo-Ping, Huang Li-Xi, Feng Qi-Sheng, Chen Li-Zhen, Lin Dong-Xin, Zeng Yi-X |
|
Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Cancer research 2003 Nov 63 (22): 8057-61. Wang Haijian, Tan Wen, Hao Bingtao, Miao Xiaoping, Zhou Gangqiao, He Fuchu, Lin Dongx |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 15, 2021
- Content source: